Cyrill A. Rentsch

Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer

Claire Biot, Cyrill A. Rentsch, Joël Gsponer et al. · Science Translational Medicine · 2012 · 270 citations

Life Sciences, Immunology, Oncology +17

ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence

Mathieu F. Chevalier, Sara Trabanelli, Julien Racle et al. · Journal of Clinical Investigation · 2017 · 220 citations · Full text

Medicine, Immunology, Oncology +17

A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival.

Osama Shahin, George N. Thalmann, Cyrill A. Rentsch et al. · PubMed · 2003 · 209 citations

Medicine, Oncology, Surgery +7

A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival

Osama Shahin, George N. Thalmann, Cyrill A. Rentsch et al. · The Journal of Urology · 2003 · 208 citations

Medicine, Oncology, Urology +6

Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer

Jeroen T. Buijs, Nico V. Henriquez, Petra G.M. van Overveld et al. · Cancer Research · 2007 · 203 citations

Medicine, Molecular Biology, Oncology +17